Cite
van der Kaaij RT, Braam HJ, Boot H, et al. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. JMIR Res Protoc. 2017;6(7):e136doi: 10.2196/resprot.7790.
van der Kaaij, R. T., Braam, H. J., Boot, H., Los, M., Cats, A., Grootscholten, C., Schellens, J. H., Aalbers, A. G., Huitema, A. D., Knibbe, C. A., Boerma, D., Wiezer, M. J., van Ramshorst, B., & van Sandick, J. W. (2017). Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. JMIR research protocols, 6(7), e136. https://doi.org/10.2196/resprot.7790
van der Kaaij, Rosa T, et al. "Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study." JMIR research protocols vol. 6,7 (2017): e136. doi: https://doi.org/10.2196/resprot.7790
van der Kaaij RT, Braam HJ, Boot H, Los M, Cats A, Grootscholten C, Schellens JH, Aalbers AG, Huitema AD, Knibbe CA, Boerma D, Wiezer MJ, van Ramshorst B, van Sandick JW. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. JMIR Res Protoc. 2017 Jul 13;6(7):e136. doi: 10.2196/resprot.7790. PMID: 28705789; PMCID: PMC5532515.
Copy
Download .nbib